The G20 Summit, held for the first time on the African continent in Cape Town in May 2026, was marked by a historic financial commitment to combating antimicrobial resistance in Africa. A donor consortium including the European Union, the United States, the United Kingdom, Japan, and the Bill & Melinda Gates Foundation announced the mobilization of one billion dollars over five years (2026-2031) to support African efforts against AMR. This commitment, the largest ever dedicated specifically to AMR in Africa, will be channeled through an innovative financing mechanism jointly managed by Africa CDC, WHO, and the World Bank. Funds will be distributed across four priorities: strengthening surveillance systems (30%), improving access to diagnostics (25%), supporting antimicrobial stewardship programs (25%), and research and development of new solutions (20%). African Union Chairperson Moussa Faki Mahamat described this commitment as "a long-overdue recognition that AMR in Africa is a global problem requiring global solutions." He emphasized that Africa bears 24% of the global AMR burden while receiving only 3% of global funding dedicated to this threat. Civil society organizations welcomed the announcement while stressing the need for robust transparency mechanisms. "Money is necessary but not sufficient," said Dr. Manica Balasegaram, director of the Global Antibiotic Research and Development Partnership (GARDP). "What matters is how these funds will be spent and who will truly benefit."